Cardio AI Launches the website of it Revolutionary Platform with 10+AI Models, Transforming Cardiovascular care.

Cardio AI, a pioneering healthcare technology company, today announced the launch of its comprehensive AI-powered cardiovascular diagnostic platform. The platform introduces five advanced risk calculators for acute myocardial infarction (AMI), stroke, heart failure, sudden cardiac death (SCD), and atrial fibrillation; five specialized AI diagnostic agents for arrhythmia detection, heart failure analysis, coronary artery disease assessment, cardiomyopathy evaluation, and STEMI (heart attack) detection; a Master Orchestrator unified clinical decision support system; IoMT integration with wearable devices and medical monitors; PACS/DICOM integration for medical imaging analysis with FHIR and HL7 compliance; and a groundbreaking Women's Health Cardiology module addressing pregnancy-specific cardiovascular risks in the $500 billion maternal care market. The platform is backed by enterprise-grade security infrastructure with HIPAA compliance, SOC 2 Type II certification, and ISO 27001 certification, featuring AES-256 encryption, mandatory multi-factor authentication, and 24/7 security monitoring.

This comprehensive launch represents a major advancement in clinical decision support, combining cutting-edge artificial intelligence with real-world clinical workflows to improve patient outcomes and streamline cardiovascular care delivery. The platform serves healthcare organizations of all sizes with flexible pricing packages ranging from $40 per member per month for small practices to custom enterprise solutions for large health systems.

🎯 Comprehensive Platform Features

Five CVD Risk Calculators: Advanced machine learning models for AMI, Stroke, Heart Failure, SCD, and Atrial Fibrillation with ≥0.78-0.80 accuracy
Five AI Diagnostic Agents: Specialized agents for Arrhythmia, Heart Failure, CAD, Cardiomyopathy, and STEMI detection with continuous learning capabilities
Master Orchestrator Platform: Unified clinical decision support system integrating all diagnostic tools and patient data streams
IoMT Integration: Real-time monitoring from Apple Watch, Fitbit, ECG monitors, and blood pressure devices via MQTT/Kafka streaming
PACS/DICOM Integration: Medical imaging analysis for cardiac CT, MRI, and echocardiography with FHIR and HL7 compliant data exchange
Women's Health Cardiology: Specialized obstetrics cardiology platform addressing pregnancy-specific cardiovascular risks including preeclampsia and peripartum cardiomyopathy

The comprehensive platform architecture combines multiple cutting-edge technologies into a unified ecosystem. The five risk calculators utilize deep learning algorithms trained on large-scale cohort studies to achieve industry-leading accuracy in predicting cardiovascular events. The five AI diagnostic agents employ continuous learning mechanisms to improve diagnostic precision with each patient interaction. The Master Orchestrator serves as the central nervous system, intelligently routing data and coordinating insights across all modules. Complementing these core capabilities, the platform's dedicated Women's Health Cardiology module addresses a critical $500 billion market opportunity with pregnancy-specific risk assessment, preeclampsia prediction, gestational hypertension monitoring, and peripartum cardiomyopathy detection—filling a significant gap in maternal cardiovascular care that contributes to rising maternal mortality rates.

"Cardiovascular disease remains the leading cause of death globally, yet many at-risk patients go undiagnosed until it's too late. Our platform leverages the latest advances in artificial intelligence to provide clinicians with powerful, evidence-based tools that can identify risk earlier, diagnose conditions faster, and ultimately save lives. The addition of our Women's Health module addresses a particularly underserved population where traditional risk models often fall short."

— Sampson Kontomah, Founder & CEO, Cardio AI

The platform's Master Orchestrator serves as a unified clinical command center, seamlessly integrating data from electronic health records (EHRs), wearable devices, medical imaging systems, and laboratory results. This comprehensive approach enables healthcare providers to access real-time, AI-generated insights within their existing workflows, eliminating the need for multiple standalone systems.

🔬 Technical Innovation & Validation

Digital Clinical Trials: Ongoing multi-site validation of 5 specialized agents and risk calculators with external clinical validation
Deep Learning Models: Robust training on large cohort studies achieving ≥0.78-0.80 accuracy across all risk calculators
FDA Regulatory Strategy: 510(k) clearance pathway for diagnostic agents, Class II medical device classification for IoMT integration
Standards Compliance: Full FHIR and HL7 compliance enabling integration with 95%+ of hospital IT infrastructures
Academic Partnerships: Collaborations with Stanford, Cornell, and Harvard Medical School for clinical validation and research

Security and compliance are foundational to the platform's architecture. Cardio AI has implemented comprehensive HIPAA-compliant infrastructure with SOC 2 Type II certification, ISO 27001 compliance, and adherence to NIST Cybersecurity Framework standards. The platform features AES-256 encryption at rest, TLS 1.3 encryption in transit, multi-factor authentication for all users, and 24/7 security monitoring with incident response capabilities.

🔒 Enterprise-Grade Security & Compliance

HIPAA Compliant: Business Associate Agreements (BAAs) with all healthcare partners, 72-hour breach notification protocols
SOC 2 Type II Certified: Annual third-party audits verifying security, availability, and confidentiality controls
ISO 27001 Certified: International standard for information security management systems
Data Encryption: AES-256 at rest, TLS 1.3 in transit, Hardware Security Module (HSM) key management
Access Controls: Mandatory MFA, role-based access control (RBAC), automatic session timeouts
Comprehensive Policies: Public Privacy Policy, Terms of Service, and Security Policy pages detailing all practices

The platform offers flexible pricing packages designed to serve healthcare organizations of all sizes. The Starter tier ($40 per member per month) provides essential risk assessment tools for small practices, while the Professional tier ($80 PMPM) delivers the complete AI diagnostic suite for growing organizations. Enterprise solutions offer unlimited capacity with custom AI model training and white-label options for large healthcare systems.

💰 Flexible Service Packages

Starter Package ($40 PMPM): 3 risk calculators, up to 500 patients, basic clinical decision support, HIPAA-compliant platform
Professional Package ($80 PMPM): All 5 risk calculators, 3 AI agents, Master Orchestrator access, up to 2,000 patients, IoMT integration, priority support
Enterprise Package (Custom Pricing): Full platform access, unlimited patients, complete IoMT and PACS integration, Women's Health module, 24/7 support, dedicated account manager
Additional Services: Comprehensive training programs, implementation support, custom analytics, and clinical consulting services available

Cardio AI has also established strategic partnerships with leading academic medical centers and technology providers. The company's Technology Explorer platform showcases six interactive sections demonstrating the platform's capabilities, while integration partnerships with Epic, Cerner, and other major EHR vendors ensure seamless deployment within existing healthcare IT ecosystems.

"The integration of advanced AI with clinical workflows represents the future of cardiovascular medicine. What sets Cardio AI apart is their comprehensive approach—they're not just building isolated tools, but creating an entire ecosystem that addresses the full spectrum of cardiovascular care, from prevention to acute intervention. The focus on women's health is particularly timely and necessary."

— Dr. Tamanna Nahar, Chief Medical Advisor, Cardio AI

The platform is currently preparing for active deployment with select healthcare partners and accepting new applications for early access. Healthcare organizations interested in implementing Cardio AI can request a demonstration through the company's website, where interactive demos of all major platform features are available for exploration.

📈 Market Impact & Industry Recognition

$5 Million Seed Round: Raising funding to accelerate platform development, clinical validation and market expansion
73+ Open Positions: Aggressive hiring across engineering, clinical, sales, and operations to support rapid growth
2026-2027 Roadmap: Planned expansion into additional cardiac subspecialties, international markets, and advanced imaging AI
Academic Collaboration: Active research partnerships with Stanford, Cornell, and Harvard for clinical validation studies
Industry Awards: Recognition for innovation in AI-powered healthcare solutions and women's health focus

About Cardio AI

Cardio AI is a healthcare technology company pioneering AI-powered clinical decision support for cardiovascular care. Founded by a team of cardiologists, data scientists, and healthcare entrepreneurs, the company's mission is to reduce cardiovascular disease burden through advanced machine learning, comprehensive risk assessment, and innovative clinical tools. Headquartered in Dublin, Ohio with operations in San Francisco, California, Cardio AI serves healthcare organizations across the United States with plans for international expansion.

The company's platform combines deep learning algorithms, real-time data integration, and evidence-based clinical protocols to provide actionable insights for cardiovascular risk assessment, diagnosis, and treatment planning. With a focus on health equity and addressing disparities in cardiovascular care—particularly for women and underserved populations—Cardio AI is committed to making advanced diagnostic capabilities accessible to healthcare providers of all sizes.

For more information, visit www.cardioailive.com or follow us on LinkedIn at linkedin.com/company/101103459

🌐 Platform Access & Resources

Main Platform: www.cardioailive.com
Technology Explorer: Interactive demos of all platform features and AI models
Services Overview: Detailed service packages, pricing, and implementation information
Careers Portal: 73+ open positions across engineering, clinical, sales, and operations
Investor Relations: Information for potential investors and partners
Privacy & Security: Comprehensive policy documentation and compliance certifications

Media Contact

Sampson Kontomah
Founder & CEO, Cardio AI
Email: tonywell@cardioailive.com
Phone: +1 614-967-8728
Website: www.cardioailive.com

Media Inquiries:
Email: support@cardioailive.com
Phone: +1 614-967-8728

Investor Relations:
Email: invest@cardioailive.com
Website: www.cardioailive.com

Note: The Team is currently working to get FDA and other regulatory approvals.

Note to editors: High-resolution images, platform screenshots, and additional materials available upon request

Cardio AI Launches the website of it Revolutionary Platform with 10+AI Models, Transforming Cardiovascular care

Comprehensive AI-powered platform features advanced diagnostic agents, unified clinical decision support, and HIPAA-compliant infrastructure serving the $500+ billion cardiovascular market